SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-23-014775
Filing Date
2023-11-27
Accepted
2023-11-27 09:29:15
Documents
14
Period of Report
2023-11-22
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K zivo_8k.htm   iXBRL 8-K 23965
  Complete submission text file 0001654954-23-014775.txt   146790

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA zivo-20231122.xsd EX-101.SCH 5720
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE zivo-20231122_lab.xml EX-101.LAB 14667
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zivo-20231122_cal.xml EX-101.CAL 898
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zivo-20231122_pre.xml EX-101.PRE 9275
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zivo-20231122_def.xml EX-101.DEF 2099
8 EXTRACTED XBRL INSTANCE DOCUMENT zivo_8k_htm.xml XML 3613
Mailing Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304
Business Address 21 E. LONG LAKE ROAD SUITE 100 BLOOMFIELD HILLS MI 48304 (248) 452 9866
Zivo Bioscience, Inc. (Filer) CIK: 0001101026 (see all company filings)

IRS No.: 870699977 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40449 | Film No.: 231437521
SIC: 2836 Biological Products, (No Diagnostic Substances)